» Articles » PMID: 36253381

Mammalian N1-adenosine PARylation is a Reversible DNA Modification

Overview
Journal Nat Commun
Specialty Biology
Date 2022 Oct 17
PMID 36253381
Authors
Affiliations
Soon will be listed here.
Abstract

Poly-ADP-ribosylation (PARylation) is regarded as a protein-specific modification. However, some PARPs were recently shown to modify DNA termini in vitro. Here, we use ultrasensitive mass spectrometry (LC-MS/MS), anti-PAR antibodies, and anti-PAR reagents to show that mammalian DNA is physiologically PARylated and to different levels in primary tissues. Inhibition of PAR glycohydrolase (PARG) increases DNA PARylation, supporting that the modification is reversible. DNA PARylation requires PARP1 and in vitro PARP1 PARylates single-stranded DNA, while PARG reverts the modification. DNA PARylation occurs at the N1-position of adenosine residues to form N1-Poly(ADP-ribosyl)-deoxyadenosine. Through partial hydrolysis of mammalian gDNA we identify PAR-DNA via the diagnostic deamination product N1-ribosyl-deoxyinosine to occur in vivo. The discovery of N1-adenosine PARylation as a DNA modification establishes the conceptual and methodological framework to elucidate its biological relevance and extends the role of PARP enzymes.

Citing Articles

Discovery of reversing enzymes for RNA ADP-ribosylation reveals a possible defence module against toxic attack.

Lu Y, Schuller M, Bullen N, Mikolcevic P, Zonjic I, Raggiaschi R Nucleic Acids Res. 2025; 53(4).

PMID: 39964479 PMC: 11833690. DOI: 10.1093/nar/gkaf069.


Poly-ADP-ribosylation dynamics, signaling, and analysis.

Al-Rahahleh R, Sobol R Environ Mol Mutagen. 2024; 65(9):315-337.

PMID: 39221603 PMC: 11604531. DOI: 10.1002/em.22623.


PARP1-driven repair of topoisomerase IIIα DNA-protein crosslinks by FEN1.

Saha L, Sun Y, Saha S, Yang X, Pommier Y Cell Rep. 2024; 43(8):114522.

PMID: 39028621 PMC: 11513513. DOI: 10.1016/j.celrep.2024.114522.


Specificity of DNA ADP-Ribosylation Reversal by NADARs.

Cihlova B, Lu Y, Mikoc A, Schuller M, Ahel I Toxins (Basel). 2024; 16(5).

PMID: 38787060 PMC: 11125620. DOI: 10.3390/toxins16050208.


Deregulated DNA ADP-ribosylation impairs telomere replication.

Wondisford A, Lee J, Lu R, Schuller M, Groslambert J, Bhargava R Nat Struct Mol Biol. 2024; 31(5):791-800.

PMID: 38714889 PMC: 11102865. DOI: 10.1038/s41594-024-01279-6.


References
1.
Matta E, Kiribayeva A, Khassenov B, Matkarimov B, Ishchenko A . Insight into DNA substrate specificity of PARP1-catalysed DNA poly(ADP-ribosyl)ation. Sci Rep. 2020; 10(1):3699. PMC: 7048826. DOI: 10.1038/s41598-020-60631-0. View

2.
Sutcu H, Matta E, Ishchenko A . Role of PARP-catalyzed ADP-ribosylation in the Crosstalk Between DNA Strand Breaks and Epigenetic Regulation. J Mol Biol. 2019; 432(6):1769-1791. DOI: 10.1016/j.jmb.2019.12.019. View

3.
Talhaoui I, Lebedeva N, Zarkovic G, Saint-Pierre C, Kutuzov M, Sukhanova M . Poly(ADP-ribose) polymerases covalently modify strand break termini in DNA fragments in vitro. Nucleic Acids Res. 2016; 44(19):9279-9295. PMC: 5100588. DOI: 10.1093/nar/gkw675. View

4.
Houl J, Ye Z, Brosey C, Balapiti-Modarage L, Namjoshi S, Bacolla A . Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death. Nat Commun. 2019; 10(1):5654. PMC: 6906431. DOI: 10.1038/s41467-019-13508-4. View

5.
Alseth I, Dalhus B, Bjoras M . Inosine in DNA and RNA. Curr Opin Genet Dev. 2014; 26:116-23. DOI: 10.1016/j.gde.2014.07.008. View